South London and Maudsley NHS Foundation Trust – Page 1919
-
HSJ Local
CCG eyes joint commissioning with local council
STRUCTURE: GPs in part of the South West are exploring opportunities for integrated commissioning with their local council.
-
NewsMortality rate indicator reveals seven acute trust outliers
Seven acute trusts have emerged as consistent outliers against the controversial mortality rate measure, with significantly more patient deaths than expected, analysis of the latest data reveals.
-
CommentNoel Plumridge: the reinvestment riddle
Where is the process for reinvesting the Nicholson efficiency savings?
-
LeaderThe fairness debate will put health back on the front pages
The health sector’s low profile won’t last long.
-
CommentMedia Watch: 'carb up' to cope with surgery trauma, advises Keogh
Health policy in the media this week.
-
NewsExclusive: Circle deal means Hinchingbrooke needs over £70m to clear debts
The deal struck between Hinchingbrooke Health Care Trust and its private sector operator means the trust needs surpluses of at least £70m over the next decade to pay off its £40m debts.
-
HSJ KnowledgeWhy collaboration is the new tool of effective peer leadership
The end of job security for senior NHS staff is giving rise to a new era in which the “peer leader” collaborates to tackle tough problems. Robin Douglas and Jane Keep explain.
-
HSJ KnowledgeMapping variation to prioritise areas needing improved outcome, quality and productivity
An “atlas” of unwarranted variation in healthcare for children is informing commissioners and empowering parents, writes Ronny Cheung.
-
NewsValue-based pricing 'will not improve' cancer drug access
Government proposals to introduce a value-based pricing system for new drugs will not significantly improve patient access to treatments, experts have warned.
-
HSJ KnowledgeWill clinical leadership be the panacea for all health service woes?
Be careful what you wish for, warns Dr Shikha Pitalia, as clinicians are burdened with expectation that their new decision making powers can right all the wrongs in the NHS.
-
HSJ KnowledgeHow to collaborate on joint strategic needs assessments
Wakefield District have pioneered a new collaborative model for building an enhanced Joint Strategic Needs Assessment. Liz Blenkinsop explains.
-
HSJ KnowledgeReducing emergency admissions in children and young people
Dr Ronny Cheung goes through the full list of indicators for child health, plus a case study on children’s epilepsy admissions in children.
-
NewsLearn from New Zealand on IT spend, NHS told
The NHS has been urged to learn from New Zealand when it comes to using IT in healthcare innovation.
-
CommentReaders' letters – 3 May 2012
Why revalidation should inform doctors’ professional development, and NHS 111 rollout fears
-
Comment
Health charities can help rescue the innovation drive
The challenging QIPP targets NHS is aiming to achieve can be helped by the voluntary sector, argues Marie Curie Cancer Care chief executive Thomas Hughes-hallet.
-
HSJ KnowledgeHow to identify - and manage - conflicts of interest
Identifying, disclosing and managing conflicts of interest will help prevent the risk of issues coming back to haunt you, advise Jonathan Hayden and Ben Troke.
-
NewsJim Easton: current squeeze 'just a rehearsal'
The current financial squeeze on health services is only a “rehearsal” for a long-term push to make the NHS financially sustainable, efficiency chief Jim Easton said today.
-
NewsDH reveals swift year-of-care tariff plans
The Department of Health has revealed details of its plans to “quickly but carefully” introduce year-of-care tariffs in a bid to cut hospital admissions and encourage community based treatment.
-
NewsCCGs to manage and reward GP performance
GP practices look set to be handed an extensive role in performance managing each other – including through the award of bonuses – under proposals being drawn up by the NHS Commissioning Board.
-
News
NICE guidance on cost-saving drug not sought by DH
The Department of Health failed to act on expert advice to commission an appraisal of a drug which could lead to savings of £100m for the NHS, it has emerged.